Current Headlines

  1. MGH Findings Suggest Novel Treatment Approach For Brain Tumors
    4/15/2014

    A team of investigators from the Massachusetts General Hospital (MGH) has identified four transcription factors characterizing the small proportion of glioblastoma cells behind the aggressiveness and treatment resistance of the brain tumor. The team’s findings suggest a novel approach to treating glioblastoma stem cells.

  2. J&J Signs Up As First Partner In TSRI’s Drug Discovery Initiative
    4/15/2014

    The Scripps Research Institute (TSRI) announced that the California-based Johnson & Johnson Innovation Center is its first collaborator in Scripps Advance, its new drug discovery initiative.

  3. FDA Develops New Potency Assay For Flu Vaccines
    4/15/2014

    Scientists at the U.S. Food and Drug Administration (FDA) has developed a new laboratory assay that could speed up the launch of pandemic influenza vaccines to the public by cutting the length of time it takes to test vaccine potency.

  4. UAB Building Drug Discovery Center To Combat West Nile Virus And Influenza
    4/15/2014

    The University of Alabama at Birmingham announced last month that it is building a new drug discovery center in order to develop drug treatments for viral infections with limited options for treatment.

  5. Scientists Find Printing 3D Tumors Could Aid Cancer Research
    4/15/2014

    Researchers at Drexel University have begun using 3D printing in order to further study the cancer cells that make up tumors.

  6. Southwest Airlines Cargo Delivers The Industry’s Top Awards
    4/15/2014

    Southwest Airlines Cargo is leader of the pack when it comes to running a successful operation. The airline was recently named the Airforwarders Association’s “Domestic Carrier of the Year” for the fifth year in a row. It also earned the Express Delivery & Logistics Association’s (XLA) “Domestic Airline of the Year.” This is the 14th year in a row Southwest has won the award.

  7. Enzyme Shows Promise For Asthma And Cancer Treatments
    4/14/2014

    Scientists from the Johns Hopkins Kimmel Cancer Center have identified the enzyme SKG1 as a promising target for asthma therapy and for bolstering effects of certain anti-cancer treatments.

     

  8. Albireo Lead Compound A4250 Shows Promise Against Liver Injury In Mice
    4/14/2014

    Swedish biotechnology company Albireo announced that its lead compound A4250 for cholestatic liver disease was successful in protecting against bile acid-mediated cholestatic liver damage in mice.

  9. UCI Team Discovers Bone Marrow Stem Cells’ Potential In Stroke Recovery
    4/14/2014

    Bone marrow stem cells may help in stroke recovery, according to a team of researchers from the University of California, Irvine’s Sue and Bill Gross Stem Cell Research Center.

  10. Irvine Scientific Announces Expansion Of BalanCD™ Product Line To Serve Vaccine Market
    4/14/2014

    Irvine Scientific is pleased to announce the launch of its BalanCD™ MDCK cell culture medium, a next generation cell culture product responding to today’s requirements for media used in cell-based vaccine manufacturing. This new flagship product expands Irvine Scientific’s current BalanCD product portfolio of animal component-free and chemically-defined media with the addition of a new purpose-built product.